TY - JOUR AU - Ferlay, J. AU - Colombet, M. AU - Soerjomataram, I. PY - 2019 DA - 2019// TI - Estimating the global cancer incidence and mortality in 2018: GLOBOCAN sources and methods JO - Int J Cancer VL - 144 UR - https://doi.org/10.1002/ijc.31937 DO - 10.1002/ijc.31937 ID - Ferlay2019 ER - TY - JOUR AU - Muro, K. AU - Chung, H. C. AU - Shankaran, V. PY - 2016 DA - 2016// TI - Pembrolizumab for patients with PD-L1-positive advanced gastric cancer (KEYNOTE-012): a multicentre, open-label, phase 1b trial JO - Lancet Oncol VL - 17 UR - https://doi.org/10.1016/S1470-2045(16)00175-3 DO - 10.1016/S1470-2045(16)00175-3 ID - Muro2016 ER - TY - JOUR AU - Taube, J. M. AU - Galon, J. AU - Sholl, L. M. PY - 2018 DA - 2018// TI - Implications of the tumor immune microenvironment for staging and therapeutics JO - Mod Pathol VL - 31 UR - https://doi.org/10.1038/modpathol.2017.156 DO - 10.1038/modpathol.2017.156 ID - Taube2018 ER - TY - JOUR AU - Sunshine, J. AU - Taube, J. M. PY - 2015 DA - 2015// TI - PD-1/PD-L1 inhibitors JO - Curr Opin Pharmacol VL - 23 UR - https://doi.org/10.1016/j.coph.2015.05.011 DO - 10.1016/j.coph.2015.05.011 ID - Sunshine2015 ER - TY - JOUR AU - Sanmamed, M. F. AU - Chen, L. PY - 2014 DA - 2014// TI - Inducible expression of B7-H1 (PD-L1) and its selective role in tumor site immune modulation JO - Cancer J VL - 20 UR - https://doi.org/10.1097/PPO.0000000000000061 DO - 10.1097/PPO.0000000000000061 ID - Sanmamed2014 ER - TY - JOUR AU - Ying, L. AU - Yan, F. AU - Meng, Q. PY - 2018 DA - 2018// TI - PD-L1 expression is a prognostic factor in subgroups of gastric cancer patients stratified according to their levels of CD8 and FOXP3 immune markers JO - Oncoimmunology. VL - 7 UR - https://doi.org/10.1080/2162402X.2018.1433520 DO - 10.1080/2162402X.2018.1433520 ID - Ying2018 ER - TY - JOUR AU - Restifo, N. P. AU - Dudley, M. E. AU - Rosenberg, S. A. PY - 2012 DA - 2012// TI - Adoptive immunotherapy for cancer: harnessing the T cell response JO - Nat Rev Immunol VL - 12 UR - https://doi.org/10.1038/nri3191 DO - 10.1038/nri3191 ID - Restifo2012 ER - TY - JOUR AU - Wherry, E. J. PY - 2011 DA - 2011// TI - T cell exhaustion JO - Nat Immunol VL - 12 UR - https://doi.org/10.1038/ni.2035 DO - 10.1038/ni.2035 ID - Wherry2011 ER - TY - JOUR AU - Francisco, L. M. AU - Salinas, V. H. AU - Brown, K. E. PY - 2009 DA - 2009// TI - PD-L1 regulates the development, maintenance, and function of induced regulatory T cells JO - J Exp Med VL - 206 UR - https://doi.org/10.1084/jem.20090847 DO - 10.1084/jem.20090847 ID - Francisco2009 ER - TY - JOUR AU - Tumeh, P. C. AU - Harview, C. L. AU - Yearley, J. H. PY - 2014 DA - 2014// TI - PD-1 blockade induces responses by inhibiting adaptive immune resistance JO - Nature. VL - 515 UR - https://doi.org/10.1038/nature13954 DO - 10.1038/nature13954 ID - Tumeh2014 ER - TY - STD TI - Vrána D, Matzenauer M, Neoral Č, et al. From tumor immunology to immunotherapy in gastric and esophageal cancer. Int J Mol Sci. 2018;20. https://doi.org/10.3390/ijms20010013. ID - ref11 ER - TY - JOUR AU - Zhang, L. AU - Qiu, M. AU - Jin, Y. PY - 2015 DA - 2015// TI - Programmed cell death ligand 1 (PD-L1) expression on gastric cancer and its relationship with clinicopathologic factors JO - Int J Clin Exp Pathol VL - 8 ID - Zhang2015 ER - TY - JOUR AU - Chang, H. AU - Jung, W. Y. AU - Kang, Y. PY - 2016 DA - 2016// TI - Programmed death-ligand 1 expression in gastric adenocarcinoma is a poor prognostic factor in a high CD8+ tumor infiltrating lymphocytes group JO - Oncotarget. VL - 7 UR - https://doi.org/10.18632/oncotarget.12603 DO - 10.18632/oncotarget.12603 ID - Chang2016 ER - TY - JOUR AU - Eto, S. AU - Yoshikawa, K. AU - Nishi, M. PY - 2016 DA - 2016// TI - Programmed cell death protein 1 expression is an independent prognostic factor in gastric cancer after curative resection JO - Gastric Cancer VL - 19 UR - https://doi.org/10.1007/s10120-015-0519-7 DO - 10.1007/s10120-015-0519-7 ID - Eto2016 ER - TY - JOUR AU - Thompson, E. D. AU - Zahurak, M. AU - Murphy, A. PY - 2017 DA - 2017// TI - Patterns of PD-L1 expression and CD8 T cell infiltration in gastric adenocarcinomas and associated immune stroma JO - Gut. VL - 66 UR - https://doi.org/10.1136/gutjnl-2015-310839 DO - 10.1136/gutjnl-2015-310839 ID - Thompson2017 ER - TY - JOUR AU - Kim, J. W. AU - Nam, K. H. AU - Ahn, S. H. PY - 2016 DA - 2016// TI - Prognostic implications of immunosuppressive protein expression in tumors as well as immune cell infiltration within the tumor microenvironment in gastric cancer JO - Gastric Cancer VL - 19 UR - https://doi.org/10.1007/s10120-014-0440-5 DO - 10.1007/s10120-014-0440-5 ID - Kim2016 ER - TY - JOUR AU - Kawazoe, A. AU - Kuwata, T. AU - Kuboki, Y. PY - 2017 DA - 2017// TI - Clinicopathological features of programmed death ligand 1 expression with tumor-infiltrating lymphocytes, mismatch repair, and Epstein-Barr virus status in a large cohort of gastric cancer patients JO - Gastric Cancer VL - 20 UR - https://doi.org/10.1007/s10120-016-0631-3 DO - 10.1007/s10120-016-0631-3 ID - Kawazoe2017 ER - TY - JOUR AU - Lauren, P. PY - 1965 DA - 1965// TI - The two histological main types of gastric carcinoma: diffuse and so called intestinal-type carcinoma. An attempt at a histo-clinical classification JO - Acta Pathol Microbiol Scand VL - 64 UR - https://doi.org/10.1111/apm.1965.64.1.31 DO - 10.1111/apm.1965.64.1.31 ID - Lauren1965 ER - TY - BOOK AU - Edge, S. B. AU - Byrd, D. R. AU - Compton, C. C. PY - 2009 DA - 2009// TI - AJCC cancer staging manual PB - Springer-Verlag CY - New York ID - Edge2009 ER - TY - JOUR AU - Schats, K. A. AU - Vré, E. A. AU - Boeckx, C. PY - 2018 DA - 2018// TI - Optimal evaluation of programmed death ligand-1 on tumor cells versus immune cells requires different detection methods JO - Arch Pathol Lab Med VL - 142 UR - https://doi.org/10.5858/arpa.2017-0159-OA DO - 10.5858/arpa.2017-0159-OA ID - Schats2018 ER - TY - JOUR AU - Ma, C. AU - Patel, K. AU - Singhi, A. D. PY - 2016 DA - 2016// TI - Programmed death-ligand 1 expression is common in gastric cancer associated with Epstein-Barr virus or microsatellite instability JO - Am J Surg Pathol VL - 40 UR - https://doi.org/10.1097/PAS.0000000000000698 DO - 10.1097/PAS.0000000000000698 ID - Ma2016 ER - TY - JOUR AU - Wang, J. AU - Reiss, K. A. AU - Khatri, R. AU - Jaffee, E. AU - Laheru, D. PY - 2015 DA - 2015// TI - Immune therapy in GI malignancies: a review JO - J Clin Oncol VL - 33 UR - https://doi.org/10.1200/JCO.2015.60.7879 DO - 10.1200/JCO.2015.60.7879 ID - Wang2015 ER - TY - JOUR AU - Kang, B. W. AU - Seo, A. N. AU - Yoon, S. PY - 2016 DA - 2016// TI - Prognostic value of tumor-infiltrating lymphocytes in Epstein-Barr virus-associated gastric cancer JO - Ann Oncol VL - 27 UR - https://doi.org/10.1093/annonc/mdv610 DO - 10.1093/annonc/mdv610 ID - Kang2016 ER - TY - JOUR AU - Bae, Y. S. AU - Kim, H. AU - Noh, S. H. AU - Kim, H. PY - 2015 DA - 2015// TI - Usefulness of immunohistochemistry for microsatellite instability screening in gastric cancer JO - Gut Liver VL - 9 UR - https://doi.org/10.5009/gnl15133 DO - 10.5009/gnl15133 ID - Bae2015 ER - TY - JOUR AU - Boland, C. R. AU - Thibodeau, S. N. AU - Hamilton, S. R. PY - 1998 DA - 1998// TI - A national cancer institute workshop on microsatellite instability for cancer detection and familial predisposition: development of international criteria for the determination of microsatellite instability in colorectal cancer JO - Cancer Res VL - 58 ID - Boland1998 ER - TY - JOUR AU - Jeong, J. Y. AU - Woo, J. H. AU - Kim, Y. S. PY - 2010 DA - 2010// TI - Nuclear factor-kappa B inhibition reduces markedly cell proliferation in Epstein-Barr virus-infected stomach cancer, but affects variably in Epstein-Barr virus-negative stomach cancer JO - Cancer Investig VL - 28 UR - https://doi.org/10.3109/07357900903095730 DO - 10.3109/07357900903095730 ID - Jeong2010 ER - TY - JOUR AU - Kim, D. H. AU - Chang, M. S. AU - Yoon, C. J. PY - 2016 DA - 2016// TI - Epstein-Barr virus BARF1-induced NFκB/miR-146a/SMAD4 alterations in stomach cancer cells JO - Oncotarget. VL - 7 UR - https://doi.org/10.18632/oncotarget.10511 DO - 10.18632/oncotarget.10511 ID - Kim2016 ER - TY - JOUR AU - Li, J. AU - Chen, L. AU - Xiong, Y. PY - 2017 DA - 2017// TI - Knockdown of PD-L1 in human gastric cancer cells inhibits tumor progression and improves the cytotoxic sensitivity to CIK therapy JO - Cell Physiol Biochem VL - 41 UR - https://doi.org/10.1159/000460504 DO - 10.1159/000460504 ID - Li2017 ER - TY - JOUR AU - Shi, S. J. AU - Wang, L. J. AU - Wang, G. D. PY - 2013 DA - 2013// TI - B7-H1 expression is associated with poor prognosis in colorectal carcinoma and regulates the proliferation and invasion of HCT116 colorectal cancer cells JO - PLoS One VL - 8 UR - https://doi.org/10.1371/journal.pone.0076012 DO - 10.1371/journal.pone.0076012 ID - Shi2013 ER - TY - JOUR AU - Chen, J. AU - Jiang, C. C. AU - Jin, L. PY - 2016 DA - 2016// TI - Regulation of PD-L1: a novel role of pro-survival signalling in cancer JO - Ann Oncol VL - 27 UR - https://doi.org/10.1093/annonc/mdv615 DO - 10.1093/annonc/mdv615 ID - Chen2016 ER - TY - STD TI - Yu J, Wang X, Teng F, et al. PD-L1 expression in human cancers and its association with clinical outcomes. Onco Targets Ther. 2016;9:5023–39. ID - ref31 ER - TY - JOUR AU - Giannakis, M. AU - Mu, X. J. AU - Shukla, S. A. PY - 2016 DA - 2016// TI - Genomic correlates of immune-cell infiltrates in colorectal carcinoma JO - Cell Rep VL - 17 UR - https://doi.org/10.1016/j.celrep.2016.10.009 DO - 10.1016/j.celrep.2016.10.009 ID - Giannakis2016 ER - TY - JOUR AU - Kim, H. R. AU - Ha, S. J. AU - Hong, M. H. PY - 2016 DA - 2016// TI - PD-L1 expression on immune cells, but not on tumor cells, is a favorable prognostic factor for head and neck cancer patients JO - Sci Rep VL - 6 UR - https://doi.org/10.1038/srep36956 DO - 10.1038/srep36956 ID - Kim2016 ER - TY - JOUR AU - Cho, J. AU - Lee, J. AU - Bang, H. PY - 2017 DA - 2017// TI - Programmed cell death-ligand 1 expression predicts survival in patients with gastric carcinoma with microsatellite instability JO - Oncotarget. VL - 8 UR - https://doi.org/10.18632/oncotarget.14519 DO - 10.18632/oncotarget.14519 ID - Cho2017 ER - TY - STD TI - Choi Y, Kim H, Shin SJ, et al. Microsatellite Instability and Programmed Cell Death-Ligand 1 Expression in Stage II/III Gastric Cancer: Post Hoc Analysis of the CLASSIC Randomized Controlled Study. Ann Surg. 2019;270:309–16. ID - ref35 ER - TY - JOUR AU - Pulko, V. AU - Harris, K. J. AU - Liu, X. PY - 2011 DA - 2011// TI - B7-H1 expressed by activated CD8 T cells is essential for their survival JO - J Immunol VL - 187 UR - https://doi.org/10.4049/jimmunol.1003976 DO - 10.4049/jimmunol.1003976 ID - Pulko2011 ER - TY - JOUR AU - Lau, J. AU - Cheung, J. AU - Navarro, A. PY - 2017 DA - 2017// TI - Tumour and host cell PD-L1 is required to mediate suppression of anti-tumour immunity in mice JO - Nat Commun VL - 8 UR - https://doi.org/10.1038/ncomms14572 DO - 10.1038/ncomms14572 ID - Lau2017 ER - TY - JOUR AU - Balkwill, F. AU - Coussens, L. M. PY - 2004 DA - 2004// TI - Cancer: an inflammatory link JO - Nature. VL - 431 UR - https://doi.org/10.1038/431405a DO - 10.1038/431405a ID - Balkwill2004 ER - TY - JOUR AU - Kim, K. J. AU - Lee, K. S. AU - Cho, H. J. PY - 2014 DA - 2014// TI - Prognostic implications of tumor-infiltrating FoxP3+ regulatory T cells and CD8+ cytotoxic T cells in microsatellite-unstable gastric cancers JO - Hum Pathol VL - 45 UR - https://doi.org/10.1016/j.humpath.2013.09.004 DO - 10.1016/j.humpath.2013.09.004 ID - Kim2014 ER - TY - JOUR AU - Haas, M. AU - Dimmler, A. AU - Hohenberger, W. PY - 2009 DA - 2009// TI - Stromal regulatory T-cells are associated with a favourable prognosis in gastric cancer of the cardia JO - BMC Gastroenterol VL - 9 UR - https://doi.org/10.1186/1471-230X-9-65 DO - 10.1186/1471-230X-9-65 ID - Haas2009 ER - TY - JOUR AU - Perrone, G. AU - Ruffini, P. A. AU - Catalano, V. PY - 2008 DA - 2008// TI - Intratumoural FOXP3-positive regulatory T cells are associated with adverse prognosis in radically resected gastric cancer JO - Eur J Cancer VL - 44 UR - https://doi.org/10.1016/j.ejca.2008.05.017 DO - 10.1016/j.ejca.2008.05.017 ID - Perrone2008 ER - TY - JOUR AU - deLeeuw, R. J. AU - Kost, S. E. AU - Kakal, J. A. PY - 2012 DA - 2012// TI - The prognostic value of FoxP3+ tumor-infiltrating lymphocytes in cancer: a critical review of the literature JO - Clin Cancer Res VL - 18 UR - https://doi.org/10.1158/1078-0432.CCR-11-3216 DO - 10.1158/1078-0432.CCR-11-3216 ID - deLeeuw2012 ER - TY - JOUR AU - Ladoire, S. AU - Martin, F. AU - Ghiringhelli, F. PY - 2011 DA - 2011// TI - Prognostic role of FOXP3+ regulatory T cells infiltrating human carcinomas: the paradox of colorectal cancer JO - Cancer Immunol Immunother VL - 60 UR - https://doi.org/10.1007/s00262-011-1046-y DO - 10.1007/s00262-011-1046-y ID - Ladoire2011 ER - TY - JOUR AU - Zou, W. AU - Chen, L. PY - 2008 DA - 2008// TI - Inhibitory B7-family molecules in the tumour microenvironment JO - Nat Rev Immunol VL - 8 UR - https://doi.org/10.1038/nri2326 DO - 10.1038/nri2326 ID - Zou2008 ER - TY - JOUR PY - 2014 DA - 2014// TI - Comprehensive molecular characterization of gastric adenocarcinoma JO - Nature. VL - 513 UR - https://doi.org/10.1038/nature13480 DO - 10.1038/nature13480 ID - ref45 ER - TY - JOUR AU - Chang, M. S. AU - Lee, H. S. AU - Kim, H. S. PY - 2003 DA - 2003// TI - Epstein-Barr virus and microsatellite instability in gastric carcinogenesis JO - J Pathol VL - 199 UR - https://doi.org/10.1002/path.1302 DO - 10.1002/path.1302 ID - Chang2003 ER - TY - JOUR AU - Kim, S. T. AU - Cristescu, R. AU - Bass, A. J. PY - 2018 DA - 2018// TI - Comprehensive molecular characterization of clinical responses to PD-1 inhibition in metastatic gastric cancer JO - Nat Med VL - 24 UR - https://doi.org/10.1038/s41591-018-0101-z DO - 10.1038/s41591-018-0101-z ID - Kim2018 ER - TY - STD TI - Mathiak M, Warneke VS, Behrens H-M, et al. Clinicopathologic characteristics of microsatellite instable gastric carcinomas revisited: urgent need for standardization. Appl Immunohistochem Mol Morphol. 2017;25:12–24. ID - ref48 ER - TY - JOUR AU - Samowitz, W. A. PY - 2015 DA - 2015// TI - Evaluation of colorectal cancers for lynch syndrome: practical molecular diagnostics for surgical pathologists JO - Mod Pathol VL - 28 UR - https://doi.org/10.1038/modpathol.2014.127 DO - 10.1038/modpathol.2014.127 ID - Samowitz2015 ER - TY - JOUR AU - Ribas, A. AU - Hu-Lieskovan, S. PY - 2016 DA - 2016// TI - What does PD-L1 positive or negative mean? JO - J Exp Med VL - 213 UR - https://doi.org/10.1084/jem.20161462 DO - 10.1084/jem.20161462 ID - Ribas2016 ER -